OGDEN, Utah--(BUSINESS WIRE)--Setpoint Systems (http://www.setpointusa.com), a leader in design and manufacture of custom lean automation solutions and manufacturing ...
The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis (RA). The ...
Procedures performed by Dr. Webster Crowley mark a milestone for neuroimmune modulation therapy in the Midwest SetPoint Medical today announced the first patients in Chicago have been treated with the ...
Credit: SetPoint Medical. The SetPoint System is a rechargeable neurostimulation device that is implanted on the vagus nerve. Treatment with the SetPoint System, a neuroimmune modulation device, was ...
An innovative new device calms inflammation by delivering a low-voltage jolt of electricity to the vagus nerve. The FDA has approved the SetPoint System, a device implanted in the neck for relieving ...
VALENCIA, Calif., February 03, 2026--(BUSINESS WIRE)--SetPoint Medical today announced the first patients in Chicago have been treated with the SetPoint System, an FDA-approved neuroimmune modulation ...
The U.S. Food and Drug Administration (FDA) has granted approval to the SetPoint System, a neuroimmune modulation device designed to treat adults with moderate-to-severe rheumatoid arthritis (RA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results